A Simple UPLC/MS-MS Method for Simultaneous Determination of Lenvatinib and Telmisartan in Rat Plasma, and Its Application to Pharmacokinetic Drug-Drug Interaction Study

A Simple UPLC/MS-MS Method for Simultaneous Determination of Lenvatinib and Telmisartan in Rat Plasma, and Its Application to Pharmacokinetic Drug-Drug Interaction Study

Lenvatinib is a multi-targeted tyrosine kinase inhibitor that inhibits tumor angiogenesis, but hypertension is the most common adverse reaction. Telmisartan is an angiotensin receptor blocker used to treat hypertension. In this study, a simple ultra-performance liquid chromatography-tandem mass spec...

Full description

Bibliographic Details
Main Authors: Yanjun Cui, Ying Li, Xiao Li, Liju Fan, Xueru He, Yuhao Fu, Zhanjun Dong
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Molecules
Subjects:
UPLC-MS/MS
lenvatinib
telmisartan
pharmacokinetics
drug-drug interaction
Online Access:https://www.mdpi.com/1420-3049/27/4/1291

Internet

https://www.mdpi.com/1420-3049/27/4/1291

Similar Items